{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-22-002217","form_type":"8-K","ticker":"ENTXW","cik":"0001638097","company_name":"Entera Bio Ltd.","filed_at":"2022-05-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.585332+00:00","generated_at":"2026-06-25T06:20:44.124648+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Entera Bio amends ATM sales agreement with B. Riley Securities to reflect loss of foreign private issuer status","bullets":["Entered into Amended and Restated At Market Issuance Sales Agreement with B. Riley Securities dated May 27, 2022.","Amendment made to reflect that Entera Bio is no longer a foreign private issuer.","All material terms of the original agreement remain unchanged.","Agreement allows for at-the-market offerings of ordinary shares under a Form S-3 registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-22-002217","json":"https://secwatch.observer/filing/0001178913-22-002217.json","markdown":"https://secwatch.observer/filing/0001178913-22-002217.md","text":"https://secwatch.observer/filing/0001178913-22-002217.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322002217/0001178913-22-002217-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322002217/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T06:20:44.124648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}